A vs MDLN

Agilent Technologies exhibits strong fundamental health with a Piotroski F-Score of 8/9, indicating robust accounting strength, and solid profitability metrics including an ROE of 20.62% and operating margin of 26.38%. The company is growing revenue and earnings at double-digit rates, supported by consistent earnings beat rates and strong cash flow generation, though key financial data like Altman Z-Score and cash/debt figures are missing. However, the stock trades at a premium valuation (P/E of 30.28 vs sector average of 215 but with much lower growth than peers), and insider selling activity raises caution. While analysts are bullish with a $169.67 target price, the technical trend is bearish and recent price performance has been weak over the past year despite a short-term rebound.

MDLN exhibits strong fundamental health with a Piotroski F-Score of 7/9 and exceptional liquidity (Current Ratio 4.29), suggesting a stable operational baseline. However, the stock is currently trading at a premium to its Intrinsic Value ($42.18) and significantly above its Graham Number ($20.63). This valuation gap, combined with a starkly bearish technical trend and massive insider liquidation exceeding $3.5 billion, offsets the positive analyst consensus and revenue growth.